Objectives: Identifying the acute symptoms of manic episode remembered by the patients can help psychiatrists improve their ability to manage bipolar disorder. Given the importance of remembering symptoms, the aim of this study was to evaluate the ability of patients with type I bipolar disorder during the euthymic period to remember their past mania symptoms after hospital discharge.
Methods: Participants were 59 patients with type I bipolar disorder admitted to Hazrat-e-Rasool-e-Akram Hospital and Iran Psychiatry Hospital in 2012. They measured by using Structured Clinical Interview for DSM-IV axis I Disorders (SCID-I) and Young Mania Rating Scale (YMRS) and their mania symptoms were recorded. Their demographic information were extracted from their medical records. Sixth months after discharge, they were evaluated again by using the 17-item Hamilton Depression Rating Scale (HRSD-17), SCID-I, YMRS, and Mini–Mental State Examination (MMSE) through face-to-face interview. To assess the agreement on the symptoms during admission and 60 months after discharge, McNemar Test and Kappa coefficients were used.
Results: most common mania symptoms remembered by the patients were decreased need for sleep (91.2%), irritability (83.9%), excessive involvement in activities with a high likelihood of painful consequences (81.3%) and the least frequent remembered symptom was distractibility (17.6%). The highest positive predictive values were related to the symptoms of irritability (100%), talkativeness (100%) and decreased need for sleep (96.3%), while the highest negative predictive value was related to elevated mood (87.5%).
Conclusion: management of patients with bipolar disorder, psychiatrists can trust the patients’ ability to remember the three mania symptoms including irritability, decreased need for sleep and talkativeness. Regarding the symptom of elevated mood in bipolar patients, negative response of patients can be trusted.

One of the best approaches for evidence-based care is providing and using the guidelines. Observing these guidelines results in a better quality of health care, decreased unnecessary or harmful interventions, lower health costs, and an increase in patients’ satisfaction. Management of Attention Deficit Hyperactivity Disorder (ADHD)-1 in children and adolescents is a guideline published after 6 years of research and review of resources in the domain of treatment of ADHD. A research team formed in Iran University of Medical Sciences provided this guideline by addressing reliable references and observing a scientific approach. This guideline is provided with respect to the present resources for the standard treatment of ADHD in our country. To prepare this guideline, this research team considered the most recent and strict version of the writing method in the treatment section of Health, Treatment, and Education Ministry. Although the present guideline has some shortcomings, it is a turning point in the history of the development of health care. It presents a systematic approach in the treatment of such disorder, one of the most prevalent disorders in child psychiatry. The colleagues and treatment centers can help such an issue by applying this guideline.